LRRK2 detection in human biofluids: potential use as a Parkinson's disease biomarker?
(se abrirá en una nueva ventana)
Autores:
Jean-Marc Taymans, Eugénie Mutez, Matthieu Drouyer, William Sibran, Marie-Christine Chartier-Harlin
Publicado en:
Biochemical Society Transactions, Edición 45/1, 2017, Página(s) 207-212, ISSN 0300-5127
Editor:
Portland Press, Ltd.
DOI:
10.1042/BST20160334
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
(se abrirá en una nueva ventana)
Autores:
Jean-Marc Taymans, Elisa Greggio
Publicado en:
Current Neuropharmacology, Edición 14/3, 2016, Página(s) 214-225, ISSN 1570-159X
Editor:
Bentham Science Publishers
DOI:
10.2174/1570159X13666151030102847
Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
(se abrirá en una nueva ventana)
Autores:
Kushal Sejwal, Mohamed Chami, Hervé Rémigy, Renée Vancraenenbroeck, William Sibran, Rosmarie Sütterlin, Paul Baumgartner, Robert McLeod, Marie-Christine Chartier-Harlin, Veerle Baekelandt, Henning Stahlberg, Jean-Marc Taymans
Publicado en:
Scientific Reports, Edición 7/1, 2017, Página(s) 8667, ISSN 2045-2322
Editor:
Nature Publishing Group
DOI:
10.1038/s41598-017-09126-z